Gulf Pharmaceutical Industries P.S.C. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was AED 415.8 million compared to AED 362.8 million a year ago. Net income was AED 4.1 million compared to AED 53.3 million a year ago. Basic earnings per share from continuing operations was AED 0.003. Basic earnings per share was AED 0.004 compared to AED 0.046 a year ago.
For the nine months, sales was AED 1,254.3 million compared to AED 746.3 million a year ago. Net income was AED 10.4 million compared to AED 103.2 million a year ago. Basic earnings per share was AED 0.009 compared to AED 0.089 a year ago.